NCCN states that all patients with active cancer, or with active, recent, or planned cancer treatment, should be considered highest priority to receive one of the COVID-19 vaccines granted emergency use authorization.
Courtney Marabella
Advertisement
Articles by Courtney Marabella
Advertisement
Latest Updated Articles
National Comprehensive Cancer Network Issues Guidance on COVID-19 Vaccination for Patients With CancerPublished: January 25th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
FDA Approves Gazyva for Active Lupus Nephritis
3
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
4
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
5
